CryoPort, Inc.

CYRX | $16.11 -2.19% -2.23% 510K

(0.0% 1d) (6.1% 1m) (-20.3% 1y) (0.0% 2d) (0.0% 3d) (-0.1% 7d) (-21.18% volume)
Earnings Calendar: 2024-03-12
Market Cap: $ 792,039,741
http://www.cryoport.com
Sec Filling | Patents | 125 employees

(US) CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. It offers personalized medicine, immunotherapies, cellular therapies, CAR T-cell therapies, stem cell therapies, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to certain ranges of precision-controlled temperatures. The company was founded on May 25, 1990 and is headquartered in Brentwood, TN.

vaccine stem cell immunotherapy cryo car-t t-cell diagnostics ceiling

add to watch list Paper trade email alert is off

Press-releases

Cryoport Reports Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-03-12 (Crawled : 20:00) - prnewswire.com
CYRX | $16.11 -2.19% -2.23% 510K

Transportation

| 4.36% | O: -11.04% H: 12.75% C: -0.97%
year financial results

Cell Cryopreservation Market Report 2024-2029, with Profiles of Key Players Irvine Scientific, Biogenuix, Cryo-Cell, Sartorius, Sigma-Aldrich, Cytiva, AMSBIO and Transgen Biotech
Published: 2024-03-11 (Crawled : 18:00) - prnewswire.com
CYRX | $16.11 -2.19% -2.23% 510K

Transportation

| 3.85% | O: -0.55% H: 2.0% C: 0.06%
report biotech cell key market

Cryoport to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024
Published: 2024-02-27 (Crawled : 14:00) - biospace.com/
CYRX | $16.11 -2.19% -2.23% 510K

Transportation

| 6.51% | O: 1.69% H: 6.47% C: 4.19%
report year financial results

2023 Acquisitions, New Facilities, and A Rebrand
Published: 2023-12-31 (Crawled : 20:20) - cryoport.com
CYRX | $16.11 -2.19% -2.23% 510K

Transportation

| Email alert Add to watchlist

Examining 2023 & 2024: Looking Back with President & CEO, Mark Sawicki
Published: 2023-12-21 (Crawled : 00:00) - cryoport.com
CYRX | $16.11 -2.19% -2.23% 510K

Transportation

| 4.81% | O: 0.68% H: 2.57% C: -1.53%
back

Cryoport and NIPPON EXPRESS HOLDINGS Form Global Strategic Partnership for Temperature-Controlled Supply Chain Services
Published: 2023-11-27 (Crawled : 13:30) - prnewswire.com
CYRX | $16.11 -2.19% -2.23% 510K

Transportation

| 15.71% | O: -0.95% H: 0.0% C: -2.88%
partnership services express global

Cryoport Reports Third Quarter 2023 Financial Results
Published: 2023-11-08 (Crawled : 21:00) - prnewswire.com
CYRX | $16.11 -2.19% -2.23% 510K

Transportation

| 65.63% | O: 11.1% H: 6.49% C: -0.96%
financial results

Cryoport to Report Third Quarter 2023 Financial Results on November 8, 2023
Published: 2023-10-25 (Crawled : 14:30) - biospace.com/
CYRX | $16.11 -2.19% -2.23% 510K

Transportation

| 56.77% | O: -1.38% H: 0.0% C: -5.05%
report financial results

Cryoport and Cell and Gene Therapy Catapult Announce Strategic Collaboration at Stevenage Manufacturing Innovation Centre for Advancement of Cell and Gene Therapies
Published: 2023-10-10 (Crawled : 13:30) - biospace.com/
CYRX | $16.11 -2.19% -2.23% 510K

Transportation

| 40.0% | O: 0.58% H: 6.37% C: 4.58%
innovation cell collaboration therapy

Be The Match BioTherapies® and Cryoport Partner to Accelerate the Development of Cell and Gene Therapies
Published: 2023-10-09 (Crawled : 20:00) - prnewswire.com
CYRX | $16.11 -2.19% -2.23% 510K

Transportation

| 40.0% | O: 0.58% H: 6.37% C: 4.58%
biotherapies cell

See all

Last 15 days Sec forms

File Id	Form	Published Date	Transaction Date	Direction	Code	Amount Transacted	Owned Amount
0001104659-24-039195	4	2024-03-27	2024-03-25	Sell	S	1079	128333
0001104659-24-039194	4	2024-03-27	2024-03-25	Sell	S	2631	692182
0001104659-24-039193	4	2024-03-27	2024-03-25	Sell	S	1367	77444
0001104659-24-036290	4	2024-03-19	2024-03-15	Buy	A	20910	20910
0001104659-24-036290	4	2024-03-19	2024-03-15	Buy	A	10455	63494
0001104659-24-036286	4	2024-03-19	2024-03-15	Buy	A	11500	11500
0001104659-24-036286	4	2024-03-19	2024-03-09	Sell	M	2666	2667
0001104659-24-036286	4	2024-03-19	2024-03-15	Buy	A	5750	129412
0001104659-24-036286	4	2024-03-19	2024-03-15	Sell	S	1035	123662
0001104659-24-036286	4	2024-03-19	2024-03-11	Sell	S	1119	124697
0001104659-24-036286	4	2024-03-19	2024-03-09	Buy	M	2666	125816